Mitsuko Suzuki

发表

TAS-116 (Pimitespib), an Oral HSP90 Inhibitor, in Combination with Nivolumab in Patients with Colorectal Cancer and Other Solid Tumors: An Open-Label, Dose-Finding, and Expansion Phase Ib Trial (EPOC1704)

A. Sato, M. Suzuki, S. Koyama, 2021, Clinical Cancer Research.